4//SEC Filing
Ryali Sriram 4
Accession 0001209191-21-020592
CIK 0001305253other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 7:38 PM ET
Size
7.4 KB
Accession
0001209191-21-020592
Insider Transaction Report
Form 4
Ryali Sriram
Chief Financial Officer
Transactions
- Award
Common Stock
2021-03-12+16,250→ 18,152 total - Award
Stock Option (Right to Buy)
2021-03-12+97,500→ 97,500 totalExercise: $9.99Exp: 2031-03-11→ Common Stock (97,500 underlying)
Footnotes (3)
- [F1]Represents shares underlying Restricted Stock Units award that will vest in three equal annual installments measured from March 12, 2021.
- [F2]Includes 274 shares acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan on March 5, 2021.
- [F3]The option vests in equal monthly installments over 48 months measured from March 12, 2021 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001762893
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 7:38 PM ET
- Size
- 7.4 KB